FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Terbinafineterbinafine hydrochloride tablet | Terbinafine hydrochloride 250 mg/1 | TabletOral | Amerisyn LLC | Aug 3, 2026 | 87564-010 |
| Metoprolol Tartrate | Metoprolol tartrate 25 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 2, 2026 | 70518-4714 |
| nisoldipine | Nisoldipine 8.5 mg/1 | Tablet, Film coated, Extended releaseOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Aug 1, 2026 | 23155-976 |
| nisoldipine | Nisoldipine 17 mg/1 | Tablet, Film coated, Extended releaseOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Aug 1, 2026 | 23155-977 |
| Cabergoline | Cabergoline .5 mg/1 | TabletOral | Cranbury Pharmaceuticals, LLC | Aug 1, 2026 | 27808-315 |
| Rosuvastatin Calcium | Rosuvastatin calcium 5 mg/1 | Tablet, Film coatedOral | Zhejiang Yongtai Pharmaceutical Co., Ltd. | Aug 1, 2026 | 69434-005 |
| Rosuvastatin Calcium | Rosuvastatin calcium 10 mg/1 | Tablet, Film coatedOral | Zhejiang Yongtai Pharmaceutical Co., Ltd. | Aug 1, 2026 | 69434-006 |
| Rosuvastatin Calcium | Rosuvastatin calcium 20 mg/1 | Tablet, Film coatedOral | Zhejiang Yongtai Pharmaceutical Co., Ltd. | Aug 1, 2026 | 69434-007 |
| Rosuvastatin Calcium | Rosuvastatin calcium 40 mg/1 | Tablet, Film coatedOral | Zhejiang Yongtai Pharmaceutical Co., Ltd. | Aug 1, 2026 | 69434-008 |
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | QUAGEN PHARMACEUTICALS LLC | Aug 1, 2026 | 70752-175 |
| Bumetanide | Bumetanide .25 mg/mL | Injection, SolutionIntramuscular, Intravenous | Civica, Inc. | Aug 1, 2026 | 72572-210 |
| Bumetanide | Bumetanide .25 mg/mL | Injection, SolutionIntramuscular, Intravenous | Civica, Inc. | Aug 1, 2026 | 72572-211 |
| Tranexamic Acid | Tranexamic acid 650 mg/1 | TabletOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-818 |
| Clozapine | Clozapine 25 mg/1 | TabletOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-911 |
| Clozapine | Clozapine 50 mg/1 | TabletOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-912 |
| Clozapine | Clozapine 100 mg/1 | TabletOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-913 |
| Clozapine | Clozapine 200 mg/1 | TabletOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-914 |
| Doxepin | Doxepin hydrochloride 3 mg/1 | TabletOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-919 |
| Doxepin | Doxepin hydrochloride 6 mg/1 | TabletOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-920 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-974 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | NorthStar Rx LLC | Aug 1, 2026 | 72603-975 |
| Ampicillinampicillin sodium | Ampicillin sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Henry Schein, Inc. | Jul 31, 2026 | 0404-9760 |
| Prucalopride | Prucalopride succinate 1 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | Jul 31, 2026 | 46708-077 |
| Prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | Jul 31, 2026 | 46708-078 |
| Prucalopride | Prucalopride succinate 1 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | Jul 31, 2026 | 62332-077 |